Clinical Characteristics and Prognosis Analysis of
Acinetobacter baumannii
bloodstream infection
inappropriate empirical antibiotic therapy
prognosis
propensity score matching
Journal
Infection and drug resistance
ISSN: 1178-6973
Titre abrégé: Infect Drug Resist
Pays: New Zealand
ID NLM: 101550216
Informations de publication
Date de publication:
2022
2022
Historique:
received:
30
08
2022
accepted:
14
11
2022
entrez:
7
12
2022
pubmed:
8
12
2022
medline:
8
12
2022
Statut:
epublish
Résumé
In view of the fact that A propensity score matching method was used to collect patients identified with A total of 398 patients were considered. According to the 28-day prognosis, they were divided into the survival group 150 (37.7%) and the death group 248 (62.3%), and the prognosis was analyzed. Subsequently, Propensity score matching was adjusted for variables with p-values <O.2 in the baseline data, equalized differences in baseline, multivariate paired logistics regression analysis was performed on 63 matched patients and showed that patients with The existence of drug resistance with
Identifiants
pubmed: 36474906
doi: 10.2147/IDR.S387898
pii: 387898
pmc: PMC9719707
doi:
Types de publication
Journal Article
Langues
eng
Pagination
6963-6974Informations de copyright
© 2022 Wang et al.
Déclaration de conflit d'intérêts
The authors report no conflicts of interest in this work.
Références
Antimicrob Resist Infect Control. 2020 Jun 19;9(1):89
pubmed: 32560670
Clin Infect Dis. 2002 Jun 15;34(12):1600-6
pubmed: 12032895
Clin Microbiol Infect. 2014 May;20(5):416-23
pubmed: 24131374
Clin Infect Dis. 2022 Jul 6;74(12):2089-2114
pubmed: 34864936
Intern Med. 2011;50(8):871-7
pubmed: 21498935
J Infect. 2008 Jan;56(1):27-34
pubmed: 18022242
Am J Infect Control. 2008 Jun;36(5):309-32
pubmed: 18538699
J Med Microbiol. 2017 Aug;66(8):1092-1101
pubmed: 28758623
Infect Drug Resist. 2020 Jul 07;13:2181-2187
pubmed: 32753914
Infect Drug Resist. 2018 Aug 21;11:1249-1260
pubmed: 30174448
BMC Infect Dis. 2016 Aug 09;16:386
pubmed: 27506948
J Infect. 2019 Aug;79(2):130-138
pubmed: 31145911
Open Forum Infect Dis. 2020 Sep 30;7(11):ofaa461
pubmed: 33209951
Pharmaceutics. 2022 Jun 14;14(6):
pubmed: 35745838
Pharmacotherapy. 2020 Sep;40(9):889-901
pubmed: 33112456
Open Forum Infect Dis. 2015 Mar 12;2(1):ofv023
pubmed: 26034772
Clin Microbiol Infect. 2013 Jun;19(6):501-9
pubmed: 23473333
Crit Care. 2006;10(2):R48
pubmed: 16563184
Lancet Infect Dis. 2018 Apr;18(4):391-400
pubmed: 29456043
Infect Drug Resist. 2018 Oct 26;11:2021-2030
pubmed: 30464544
Clin Microbiol Infect. 2012 Mar;18(3):268-81
pubmed: 21793988
Pharmaceutics. 2021 Jan 26;13(2):
pubmed: 33530483
Medicine (Baltimore). 2018 Oct;97(43):e12984
pubmed: 30412128
Clin Infect Dis. 2020 Dec 3;71(9):e497-e505
pubmed: 32069360
Front Cell Infect Microbiol. 2017 May 04;7:156
pubmed: 28523249
Nat Rev Microbiol. 2007 Dec;5(12):939-51
pubmed: 18007677
Antibiotics (Basel). 2020 Sep 28;9(10):
pubmed: 32998187
Medicine (Baltimore). 2016 Mar;95(9):e2943
pubmed: 26945403
Lancet Infect Dis. 2018 Mar;18(3):318-327
pubmed: 29276051
Lancet Infect Dis. 2021 Feb;21(2):241-251
pubmed: 32916100
Antibiotics (Basel). 2021 Apr 22;10(5):
pubmed: 33922151
Intensive Care Med. 2012 Dec;38(12):1930-45
pubmed: 23011531
Mol Biol Rep. 2021 Oct;48(10):6987-6998
pubmed: 34460060
Open Forum Infect Dis. 2020 Aug 24;7(10):ofaa378
pubmed: 33072809
Diagn Microbiol Infect Dis. 2020 Jun;97(2):115016
pubmed: 32111415
Eur J Intern Med. 2009 Sep;20(5):540-4
pubmed: 19712862
Am J Infect Control. 2019 Sep;47(9):1140-1145
pubmed: 31003750
Clin Infect Dis. 2007 Aug 1;45(3):329-37
pubmed: 17599310
PLoS One. 2015 Jun 17;10(6):e0130701
pubmed: 26083415
mSphere. 2017 Jan 18;2(1):
pubmed: 28124025
Pharmaceutics. 2021 Dec 24;14(1):
pubmed: 35056926
Am J Respir Crit Care Med. 1999 Sep;160(3):976-81
pubmed: 10471627